Blutdruckmessung und Zielblutdruck

Bernhard K. Krämer; Martin Hausberg; Bernd Sanner; Kristina Kusche-Vihrog; Joachim Weil; Burkhard Weisser; Ulrich Wenzel; Peter Trenkwalder; für die Task Force Wissenschaftliche Stellungnahmen und Leitlinien der DHL®

doi:10.1055/s-0043-117070

DMW - Deutsche Medizinische Wochenschrift, Inhaltsverzeichnis

Dtsch Med Wochenschr 2017; 142(19): 1446-1447
DOI: 10.1055/s-0043-117070

Positionspapier

Blutdruckmessung und Zielblutdruck

Stellungnahme der Deutschen Hochdruckliga e.V. DHL^®/Deutschen Gesellschaft für Hypertonie und Prävention Blood Pressure Measurement and Treatment Targets: Position Paper of the DHL^® Task Force Scientific Statements and Guidelines

Autoren

Bernhard K. Krämer
Martin Hausberg
Bernd Sanner
Kristina Kusche-Vihrog
Joachim Weil
Burkhard Weisser
Ulrich Wenzel
Peter Trenkwalder

für die Task Force Wissenschaftliche Stellungnahmen und Leitlinien der DHL^®

Abstract

Volltext

Referenzen

Literatur
1 Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2013 ESH/ESC Guidelines for the management of arterial hypertension. J Hypertens 2013; 31: 1281-1357
2 SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015; 373: 2103-2116
3 Böhm M, Schumacher H, Teo KT. et al. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Lancet 2017; 389: 2226-2237
4 Ettehad D, Emdin CA, Kiran A. et al. Blood pressure lowering for prevention of cardiovascular disease and death. Lancet 2016; 387: 957-967
5 Xie X, Atkins E, Lv J. et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes. Lancet 2016; 387: 435-443
6 Bangalore S, Toklu B, Gianos E. et al. Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials. Am J Med 2017; 130: 707-719
7 Bundy JD, Li C, Stuchlik P. et al. Systolic blood pressure reduction and risk of cardiovascular disease and mortality. JAMA Cardiol Published online May 31, 2017
8 Diederichs C, Neuhauser H. Regional variations in hypertension prevalence and management in Germany: results from the German Health Interview and Examination Survey (DEGS1). J Hypertension 2014; 32: 1405-1414
9 Lonn EM, Bosch J, Lopez-Jaramillo P. et al. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med 2016; 374: 2009-2020
10 Qaseem A, Wilt TJ, Rich R. et al. Pharmacological treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets. Ann Intern Med 2017; 166: 430-437
11 Williamson JD, Supiano MA, Applegate WB. et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥ 75 years. J Am Med Assoc 2016; 315: 2673-2682